{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T21:11:19Z","timestamp":1777669879816,"version":"3.51.4"},"reference-count":60,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2011,1,21]],"date-time":"2011-01-21T00:00:00Z","timestamp":1295568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2011,2]]},"abstract":"<jats:p><jats:bold>BACKGROUND AND PURPOSE<\/jats:bold>Melanocortins reverse circulatory shock and improve survival by counteracting the systemic inflammatory response, and through the activation of the vagus nerve\u2010mediated cholinergic anti\u2010inflammatory pathway. To gain insight into the potential therapeutic value of melanocortins against multiple organ damage following systemic inflammatory response, here we investigated the effects of the melanocortin analogue [Nle<jats:sup>4<\/jats:sup>, D\u2010Phe<jats:sup>7<\/jats:sup>]\u03b1\u2010MSH (NDP\u2010\u03b1\u2010MSH) in a widely used murine model of multiple organ dysfunction syndrome (MODS).<\/jats:p><jats:p><jats:bold>EXPERIMENTAL APPROACH<\/jats:bold>MODS was induced in mice by a single intraperitoneal injection of lipopolysaccharide followed, 6 days later (= day 0), by zymosan. After MODS or sham MODS induction, animals were randomized to receive intraperitoneally NDP\u2010\u03b1\u2010MSH (340\u2003\u00b5g\u00b7kg<jats:sup>\u22121<\/jats:sup>day) or saline for up to 16 days. Additional groups of MODS mice were concomitantly treated with the melanocortin MC<jats:sub>4<\/jats:sub>receptor antagonist HS024, or the nicotinic acetylcholine receptor antagonist chlorisondamine, and NDP\u2010\u03b1\u2010MSH.<\/jats:p><jats:p><jats:bold>KEY RESULTS<\/jats:bold>At day 7, in the liver and lung NDP\u2010\u03b1\u2010MSH, significantly reduced mRNA expression of tumour necrosis factor\u2010\u03b1 (TNF\u2010\u03b1), increased mRNA expression of interleukin\u201010 and improved the histological picture, as well as reduced TNF\u2010\u03b1 plasma levels; furthermore, NDP\u2010\u03b1\u2010MSH dose\u2010dependently increased survival rate, as assessed throughout the 16 day observation period. HS024 and chlorisondamine prevented all the beneficial effects of NDP\u2010\u03b1\u2010MSH in MODS mice.<\/jats:p><jats:p><jats:bold>CONCLUSIONS AND IMPLICATIONS<\/jats:bold>These data indicate that NDP\u2010\u03b1\u2010MSH protects against experimental MODS by counteracting the systemic inflammatory response, probably through brain MC<jats:sub>4<\/jats:sub>receptor\u2010triggered activation of the cholinergic anti\u2010inflammatory pathway. These findings reveal previously undescribed effects of melanocortins and could have clinical relevance in the MODS setting.<\/jats:p>","DOI":"10.1111\/j.1476-5381.2010.01098.x","type":"journal-article","created":{"date-parts":[[2010,10,29]],"date-time":"2010-10-29T17:30:00Z","timestamp":1288373400000},"page":"917-928","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Melanocortins protect against multiple organ dysfunction syndrome in mice"],"prefix":"10.1111","volume":"162","author":[{"given":"Alessandra","family":"Bitto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Polito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenica","family":"Altavilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Irrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Giuliani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Ottani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Letteria","family":"Minutoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Spaccapelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Galantucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renzo","family":"Lodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Guzzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Guarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Squadrito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,1,21]]},"reference":[{"issue":"1","key":"e_1_2_8_2_1","first-page":"S1","article-title":"Guide to Receptors and Channels (GRAC), 4th edition","volume":"158","author":"Alexander SPH","year":"2009","journal-title":"Br J Pharmacol"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0702038"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.shk.0000209539.91553.82"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0196-9781(95)00043-J"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1997.01430310017002"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.shk.0000228172.32587.7a"},{"key":"e_1_2_8_8_1","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0022-3565(24)29636-1","article-title":"Protective effect of melanocortin peptides in rat myocardial ischemia","volume":"297","author":"Bazzani C","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/10739680490425930"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(86)90424-3"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(86)90179-2"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/35013070"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0706426"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200005000-00024"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.56.1.1"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature01326"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.854612"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000153416.41398.A9"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200101000-00022"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2009.05.024"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2005.06.022"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2006.03.038"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-0692"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707115"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2009.03.009"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-6354-3_6"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1986.01400080039006"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/0031-6989(87)90068-3"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199008000-00014"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1996.tb15673.x"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701264"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(97)01210-7"},{"key":"e_1_2_8_33_1","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0022-3565(24)35205-X","article-title":"Evidence that melanocortin 4 receptor mediates hemorrhagic shock reversal caused by melanocortin peptides","volume":"291","author":"Guarini S","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000050627.90734.ED"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2004.03.029"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/00024382-199710000-00005"},{"key":"e_1_2_8_37_1","first-page":"57","article-title":"Involvement of proopiomelanocortin\u2010derived peptides in endogenous central istamine\u2010induced reversal of critical haemorrhagic hypotension in rats","volume":"55","author":"Jochem J","year":"2004","journal-title":"J Physiol Pharmacol"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1994.tb39654.x"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1089\/089771503321532833"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/shk.0b013e318145a7c1"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000186762.05301.13"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05631-8"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2008.140"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2010.03.052"},{"key":"e_1_2_8_45_1","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/oxfordjournals.bmb.a072630","article-title":"Involvement of oxygen radicals in shock related cell injury","volume":"49","author":"Redl H","year":"1993","journal-title":"Br Med Bull"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2009.02098.x"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/0300-9572(91)90044-Y"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005373-199805000-00022"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005373-199610000-00010"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0702848"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-197308000-00001"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0b013e31818b1e04"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature01321"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI30555"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2009.07.010"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(03)01780-1"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200207000-00026"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000130725.52373.e7"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.shk.0000155350.95435.28"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199901213400307"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.1006\/phrs.2000.0725"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.2010.01098.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.2010.01098.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T11:37:17Z","timestamp":1740656237000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.2010.01098.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,21]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["10.1111\/j.1476-5381.2010.01098.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.2010.01098.x","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,21]]},"assertion":[{"value":"2011-01-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}